rs114447363

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_139318.5(KCNH5):​c.736G>T​(p.Ala246Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000421 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

KCNH5
NM_139318.5 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 2.75

Publications

1 publications found
Variant links:
Genes affected
KCNH5 (HGNC:6254): (potassium voltage-gated channel subfamily H member 5) This gene encodes a member of voltage-gated potassium channels. Members of this family have diverse functions, including regulating neurotransmitter and hormone release, cardiac function, and cell volume. This protein is an outward-rectifying, noninactivating channel. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
KCNH5 Gene-Disease associations (from GenCC):
  • infantile-onset epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy 112
    Inheritance: AD Classification: STRONG Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.070967555).
BP6
Variant 14-62981078-C-A is Benign according to our data. Variant chr14-62981078-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 574962.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00019 (29/152302) while in subpopulation AFR AF = 0.000649 (27/41574). AF 95% confidence interval is 0.000458. There are 0 homozygotes in GnomAd4. There are 12 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 29 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNH5NM_139318.5 linkc.736G>T p.Ala246Ser missense_variant Exon 6 of 11 ENST00000322893.12 NP_647479.2
KCNH5NM_172375.3 linkc.736G>T p.Ala246Ser missense_variant Exon 6 of 10 NP_758963.1
KCNH5XM_047431275.1 linkc.736G>T p.Ala246Ser missense_variant Exon 6 of 10 XP_047287231.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNH5ENST00000322893.12 linkc.736G>T p.Ala246Ser missense_variant Exon 6 of 11 1 NM_139318.5 ENSP00000321427.7
KCNH5ENST00000420622.6 linkc.736G>T p.Ala246Ser missense_variant Exon 6 of 10 1 ENSP00000395439.2
KCNH5ENST00000394964.3 linkn.901G>T non_coding_transcript_exon_variant Exon 6 of 7 1
KCNH5ENST00000394968.2 linkc.562G>T p.Ala188Ser missense_variant Exon 6 of 11 2 ENSP00000378419.1

Frequencies

GnomAD3 genomes
AF:
0.000191
AC:
29
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000637
AC:
16
AN:
251332
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.000861
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000267
AC:
39
AN:
1461856
Hom.:
0
Cov.:
31
AF XY:
0.0000275
AC XY:
20
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.000986
AC:
33
AN:
33478
American (AMR)
AF:
0.0000671
AC:
3
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111994
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000190
AC:
29
AN:
152302
Hom.:
0
Cov.:
32
AF XY:
0.000161
AC XY:
12
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000649
AC:
27
AN:
41574
American (AMR)
AF:
0.000131
AC:
2
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000136
Hom.:
0
Bravo
AF:
0.000314
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000577
AC:
7

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Apr 12, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.736G>T (p.A246S) alteration is located in exon 6 (coding exon 6) of the KCNH5 gene. This alteration results from a G to T substitution at nucleotide position 736, causing the alanine (A) at amino acid position 246 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Developmental and epileptic encephalopathy Benign:1
Nov 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
25
DANN
Benign
0.72
DEOGEN2
Benign
0.41
T;.;.
Eigen
Benign
-0.19
Eigen_PC
Benign
0.053
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.92
D;D;D
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.071
T;T;T
MetaSVM
Uncertain
0.37
D
MutationAssessor
Benign
1.1
L;L;.
PhyloP100
2.8
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
0.35
N;N;N
REVEL
Uncertain
0.39
Sift
Benign
0.90
T;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.012
B;B;B
Vest4
0.38
MVP
0.58
MPC
0.73
ClinPred
0.040
T
GERP RS
5.5
Varity_R
0.16
gMVP
0.58
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114447363; hg19: chr14-63447796; COSMIC: COSV108105929; API